Tc99mLabelingReactionpHOptimizationTool

Tc-99m Labeling Reaction pH Optimization Tool

api RPH Tc-99m renal imaging nuclear medicine CSV→JSON URS & FS rule-based
Open selection

Utility description: Tc-99m Labeling Reaction pH Optimization Tool

Tc-99m Labeling Reaction pH Optimization Tool — pH optimization for labeling reaction

ℹ️  Utility calculates the required buffer volume to achieve target pH:
    • Considers drug type (DMSA, MAG3, HMPAO...)
    • Calculates buffer volume without excessive dilution
    • Assesses complex instability risk

⚠️  CRITICAL: Incorrect pH is the main cause of labeling failure!
    DMSA requires acidic media, HMPAO requires alkaline. Error leads to hydrolysis.
    Do not add more than 20% buffer relative to eluate volume.

Usage:
  Tc99mLabelingReactionpHOptimizationTool.exe                            → demo mode (console output)
  Tc99mLabelingReactionpHOptimizationTool.exe input.csv output.json      → evaluate your data

Input format:
KitName,EluateVolumeML,EluatePH,TargetPH,LigandBufferCapacity,BufferType,BufferConcentrationM,BufferPH

Example:
  Tc99m-DMSA,5.0,5.5,5.0,0.5,Citrate,0.1,4.5

— WHY IS THIS NEEDED?
Tc-99m generator eluate has variable pH (usually 4.5-7.5), depending on generator age and elution volume.
Each radiopharmaceutical requires a strictly defined pH for stable complexation:
• DMSA: pH 4.0-6.0 (acidic media prevents Sn hydrolysis and stabilizes complex).
• MAG3: pH 5.0-7.0 (neutral/slightly acidic for optimal kinetics).
• HMPAO: pH 7.0-8.5 (alkaline media is necessary for lipophilic complex formation).
• DTPA: pH 4.0-8.0 (wide range, but neutral is better).

⚠️  CRITICAL:
• Adding too much buffer dilutes the specific activity of the drug.
• Using wrong buffer type (e.g., phosphate instead of citrate) may lead to technetium precipitation.
• pH must be checked AFTER adding all components, but BEFORE heating (if required).
• Buffer must be apyrogenic and sterile.

Key features:
• Database of optimal pH for main Tc-99m drugs.
• Buffer volume calculation considering its concentration and pH.
• Warning about excessive dilution (>25% volume).
• Complex stability assessment under given conditions.
• Support for various buffer types (Citrate, Phosphate, Acetate, Carbonate).

Critical parameters:
• Target pH: must fall within narrow drug range
• Buffer volume: < 20-25% of eluate volume
• Buffer concentration: 0.05–0.5 M
• Stability: Score > 7/10

💡 Usage tips:
1. Always use micropipettes for adding small buffer volumes.
2. If calculation shows need for large buffer volume, use more concentrated buffer solution.
3. For HMPAO, pH stabilization is critical in first 30 minutes after labeling.
4. Check pH with indicator strips if no electronic pH meter for small volumes is available.
5. Record actual pH in the preparation protocol for each batch.

⚠️ Note: pH is the "invisible killer" of radiopharmaceutical quality. Visually the solution may look clear, but if pH is shifted by 0.5 units, labeling efficiency may drop from 98% to 60%, leading to false diagnoses in patients. This utility eliminates human factor in this complex chemical balance.

input.csv

KitName,EluateVolumeML,EluatePH,TargetPH,LigandBufferCapacity,BufferType,BufferConcentrationM,BufferPH
Tc99m-DMSA,5.0,5.5,5.0,0.5,Citrate,0.1,4.5
Tc99m-MAG3,10.0,6.0,6.5,1.0,Phosphate,0.2,7.0
Tc99m-HMPAO,5.0,5.0,7.5,0.8,Carbonate,0.1,9.0

URS & FS — user requirements and functional specification

URS — User Requirements Specification

  • The utility shall accept input.csv with the headers defined by the data contract.
  • Before calculation, the utility shall detect missing fields, type errors and invalid values.
  • The utility shall deterministically perform “Tc-99m Labeling Reaction pH Optimization Tool”.
  • The checks shall include the following criteria: Target pH: must fall within narrow drug range; Buffer volume: < 20-25% of eluate volume; Buffer concentration: 0.05–0.5 M; Stability: Score > 7/10.
  • Each processed record shall receive a clear PASS, WARNING or FAIL status with the reason.
  • The result shall be written to output.json and retain the source values used for the checks.
  • The result supports batch-data review; release remains with authorised QA/QC personnel.

FS — Functional Specification

  1. Run Tc99mLabelingReactionpHOptimizationTool.exe in demo mode or with input.csv output.json arguments.
  2. Read UTF-8 CSV and validate the header and mandatory columns.
  3. Convert values to the expected types and validate admissibility.
  4. Perform the calculation or rule checks for “Tc-99m Labeling Reaction pH Optimization Tool”.
  5. Create individual check results and the overall status.
  6. Write machine-readable JSON; invalid input shall not appear as a successful result.

input.csv example

KitName,EluateVolumeML,EluatePH,TargetPH,LigandBufferCapacity,BufferType,BufferConcentrationM,BufferPH
Tc99m-DMSA,5.0,5.5,5.0,0.5,Citrate,0.1,4.5

Minimum output.json structure

{
  "utility": "Tc99mLabelingReactionpHOptimizationTool",
  "source": "input.csv",
  "status": "PASS|WARNING|FAIL",
  "checks": [
    {
      "parameter": "example",
      "status": "PASS",
      "message": "criterion satisfied"
    }
  ],
  "errors": []
}

Before operational use

  • Limits and coefficients shall be approved before operational use.
  • After an executable or rule change, repeat the affected tests.
  • Retain the source CSV and JSON result together in the controlled process.

Included in packages

Radiopharmaceutical Diagnostics and Therapy QC Suite

36 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.

Open

RPH isotope family: Tc-99m

Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH Tc-99m Renal Radiopharmaceutical and Imaging QC Suite

16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.

Open

RPH use case: Tc-99m renal and nephrourology

Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open